Letter to the Editor
British Journal of Cancer (2007) 96, 679–680. doi:10.1038/sj.bjc.6603604 www.bjcancer.com
Published online 6 February 2007
Reply: The long-term response to imatinib treatment of CML
F Michor1
1Society of Fellows, Harvard University, Cambridge, MA 02138, USA
Correspondence: Dr F Michor, E-mail: michor@fas.harvard.edu
Top of page
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated
REVIEWS
The role of translation in neoplastic transformation from a pathologist's point of view
Oncogene Review
RESEARCH
Leukemia Original Article
Leukaemia stem cells: hit or miss?
British Journal of Cancer Letter
Leukemia Original Article
Nature Medicine Letter (01 Nov 2006)
